Comparison of Cumulative Corticosteroid Doses for Critically Ill Patients with COVID-19

Comparison of Cumulative Corticosteroid Doses for Critically Ill Patients with COVID-19

Introduction: Dexamethasone is the first medication that improved survival in patients with Coronavirus disease-2019 (COVID-19); however, the effects of corticosteroids with different cumulative doses on disease outcome must be elucidated. Our study aimed to compare clinical features, hospital morta...

Full description

Bibliographic Details
Main Authors:	Burçin HALAÇLI, Gülay TÖK, Mehmet YILDIRIM, İsmail Tuna GELDİGİTTİ, Ebru ORTAÇ ERSOY, Arzu TOPELİ
Format:	Article
Language:	Turkish
Published:	Galenos Yayinevi 2023-01-01
Series:	Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:	dexamethasone methylprednisolone intensive care coronavirus sars-cov-2
Online Access:	https://mjima.org/abstract.php?id=361

Similar Items

Comparison of critically ill COVID-19 and influenza patients with acute respiratory failure
by: Mehmet Yildirim, et al.
Published: (2022-05-01)

Comparative Efficacy of Inhaled and Intravenous Corticosteroids in Managing COVID-19-Related Acute Respiratory Distress Syndrome
by: Ahmed A. Abdelkader, et al.
Published: (2024-07-01)

Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent
by: Vijay K. Patel, et al.
Published: (2021-11-01)

Drug utilization of corticosteroid in post-operative cataract patients at Klinik Mata Utama (KMU) Madura
by: Riyadatus Solihah, et al.
Published: (2023-06-01)

Corticosteroids on the Management of Coronavirus Disease 2019 (COVID-19): A Systemic Review and Meta-Analysis
by: Mahmoud YOUSEFIFARD, et al.
Published: (2020-07-01)

Pharmacokinetic Study of Intranasal Dexamethasone and Methylprednisolone Compared with Intravenous Administration: Two Open-Label, Single-Dose, Two-Period, Two-Sequence, Cross-Over Study in Healthy Volunteers
by: Graciela Cárdenas, et al.
Published: (2022-12-01)

Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review
by: Jyoti Mehta, et al.
Published: (2022-02-01)

The Effectiveness of Submucosal Administration of Methylprednisolone and Dexamethasone in Comparison to Placebo after Third Molar Surgery: A Double Blinded, Parallel Arm Randomized Clinical Trial
by: Kinza Ayub, et al.
Published: (2023-01-01)

The Effectiveness of Submucosal Administration of Methylprednisolone and Dexamethasone in Comparison to Placebo after Third Molar Surgery: A Double Blinded, Parallel Arm Randomized Clinical Trial
by: Kinza Ayub, et al.
Published: (2023-01-01)

Treatment of Methylprednisolone Allergy with Dexamethasone
by: Öner Özdemir, et al.
Published: (2017-06-01)

The Effectiveness of Submucosal Administration of Methylprednisolone and Dexamethasone in Comparison to Placebo after Third Molar Surgery: A Double Blinded, Parallel Arm Randomized Clinical Trial
by: Kinza Ayub, et al.
Published: (2023-01-01)

Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis
by: Menon Vimala, et al.
Published: (2007-01-01)

Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report
by: José A Gonzales-Zamora, et al.
Published: (2020-08-01)

Pharmacokinetics/pharmacodynamics of glucocorticoids: modeling the glucocorticoid receptor dynamics and dose/response of commonly prescribed glucocorticoids
by: David Levitt
Published: (2024-10-01)

Comparison of corticosteroids types, dexamethasone, and methylprednisolone in patients hospitalized with COVID-19: A systematic review and network meta-analysis
by: Mina Morsali, et al.
Published: (2023-12-01)

Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
by: Keivan Ranjbar, et al.
Published: (2021-04-01)

Comparative efficacies of various corticosteroids for preventing postextubation stridor and reintubation: a systematic review and network meta-analysis
by: I-Jung Feng, et al.
Published: (2023-07-01)

A comparative study of the efficacy and outcome of methylprednisolone and dexamethasone in moderate to severe COVID-19 disease
by: Praveen B Gautam, et al.
Published: (2021-12-01)

Methylprednisolone pulse therapy for critically ill patients with COVID-19: a cohort study
by: Keum-Ju Choi, et al.
Published: (2023-02-01)

Adipocytokines in Graves’ orbitopathy and the effect of high-dose corticosteroids
by: Jan Schovanek, et al.
Published: (2021-01-01)

Comparison of Low-Versus High-Dose Steroids in the Clinical Outcome of Hospitalized COVID-19 Patients
by: Zubia Jamil, et al.
Published: (2021-12-01)

Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone
by: Alessandro Russo, et al.
Published: (2022-06-01)

Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
by: Nicola Veronese, et al.
Published: (2020-04-01)

Efficacy of dexamethasone combined with intravenous immunoglobulin for the treatment of pediatric autoimmune encephalitis
by: Xiaolin Zhou, et al.
Published: (2025-03-01)

Analgesic Quality Improvement in Paravertebral Blocks for Pediatric Nuss Procedure: An Exploratory Report on the Effects of Perineural Combined Glucocorticoids
by: Donham RN, et al.
Published: (2025-01-01)

Methylprednisolone Acetate Versus Dexamethasone Injection for Trigger Finger: A Double-blind Randomized Controlled Trial
by: Porames Suwanno, et al.
Published: (2021-07-01)

Methylprednisolone vs Dexamethasone in Management of COPD Exacerbation; a Randomized Clinical Trial
by: Mohammad Emami Ardestani, et al.
Published: (2016-12-01)

Methylprednisolone vs Dexamethasone in Management of COPD Exacerbation; a Randomized Clinical Trial
by: Mohammad Emami Ardestani, et al.
Published: (2018-12-01)

Comparative Study on the Effect of Prime Solution Included Dexamethasone Vs. Methyl Prednisone on Incidence of Postoperative Delirium in Patients with Open Heart Surgery by Cardio Pulmonary Bypass Circuit
by: Mahdi Fathi, et al.
Published: (2021-03-01)

Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
by: Khalid Al Sulaiman, et al.
Published: (2023-08-01)

A systematic review and meta-analysis of glucocorticoids treatment in severe COVID-19: methylprednisolone versus dexamethasone
by: Shukun Hong, et al.
Published: (2023-05-01)

Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: a randomized clinical trial
by: Zahra Habibi Dastenae, et al.
Published: (2022-09-01)

Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study
by: Ohoud Aljuhani, et al.
Published: (2024-02-01)

Neurological complications during the course of severe COVID-19: is it just the tip of the iceberg?
by: Gulcin Koc Yamanyar, et al.
Published: (2022-02-01)

The impact of dexamethasone versus methylprednisolone upon neutrophil/lymphocyte ratio in COVID-19 patients admitted to ICU and its implication upon mortality
by: OM Soliman, et al.
Published: (2022-12-01)

Variants of intensification of immunosuppressive therapy of rheumatoid arthritis
by: E A Vasiljeva, et al.
Published: (2007-04-01)

The usage of immunosuppressant agents and secondary infections in patients with COVID-19 in the intensive care unit: a retrospective study
by: Zeynep Tugce Sarikaya, et al.
Published: (2024-09-01)

Genetic variability in the glucocorticoid pathway and treatment outcomes in hospitalized patients with COVID-19: a pilot study
by: Patricija Štampar, et al.
Published: (2024-07-01)

Retrospective Comparison of Hospital Outcomes among Mechanically Ventilated COVID-19 Patients in ICU Who Received Methylprednisolone or Dexamethasone
by: Mariangela Canaan, et al.
Published: (2023-04-01)

Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis
by: Chaomin Wu, et al.
Published: (2020-11-01)